CSTL Castle Biosciences RESULTS: Q2, Q2 Operating Income $-3.07M, Q2 Net Income $-2.06M, Q2 REV $103.546M vs. EST $86.2M, Q2 operating expen
CSTL Castle Biosciences RESULTS: Q2, Q2 Operating Income $-3.07M, Q2 Net Income $-2.06M, Q2 REV $103.546M vs. EST $86.2M, Q2 operating expenses $106.616M, Q2 pretax profit $-1.69M
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.